Vascular cell adhesion molecule 1 mRNA 3' untranslated region (VCAM-1 mRNA 3' UTR)

The Vascular cell adhesion molecule 1 (VCAM-1) mRNA 3' untranslated region (UTR) is a critical regulatory segment of the VCAM-1 transcript that governs protein expression levels through post-transcriptional mechanisms. VCAM-1 itself is a cell surface glycoprotein expressed on activated endothelial cells, where it facilitates the recruitment of leukocytes during inflammatory responses (UniProt P19320). The 3' UTR contains specific binding sites for microRNAs, most notably miR-126, which has been shown to negatively regulate VCAM-1 expression to maintain vascular homeostasis (Harris et al., 2008, PNAS). Dysregulation of VCAM-1 expression is strongly linked to the pathogenesis of atherosclerosis, chronic inflammatory diseases, and cancer metastasis, where it promotes leukocyte infiltration and tumor cell adhesion (PubMed: 18305172). Targeting the VCAM-1 mRNA 3' UTR with antisense oligonucleotides or microRNA mimics represents a therapeutic strategy to downregulate VCAM-1 protein levels and mitigate vascular inflammation. This approach offers a more precise method of modulation compared to broad-spectrum anti-inflammatory agents by specifically interfering with the regulatory elements of the VCAM-1 message. Current research focuses on optimizing delivery systems to target these RNA-based therapies to inflamed vascular beds while minimizing off-target effects.

Other names

CD106 mRNA 3' UTRVascular cell adhesion protein 1 mRNA 3' UTRINCAM-100 mRNA 3' UTRVCAM1 3' UTR

Post-transcriptional gene silencing via mRNA degradation or translational inhibition by binding to regulatory sequences within the 3' untranslated region.